Organization · Venture Studio
BioHebe LLC
BioHebe LLC is a New York City-based organization focused on preclinical business development and company formation for therapies targeting degenerative and chronic diseases. It collaborates with academic and healthcare institutions to advance innovative therapies.
Overview
What BioHebe LLC does
What BioHebe LLC is
BioHebe LLC is a New York City-based organization focused on preclinical business development and company formation for therapies targeting degenerative and chronic diseases. It collaborates with academic and healthcare institutions to advance innovative therapies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Studio
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- May 3, 2026
What Venture studio means
A venture studio is an organization that systematically creates new startups by generating or sourcing ideas, validating them, building early products, recruiting founders or operators, providing shared resources, and retaining meaningful equity in the companies it helps create.
Open the glossary entryOfficial channels
Find BioHebe LLC elsewhere
Open the official website or a supported primary organization account.
Capability profile
BioHebe LLC as a funder
Investment thesis
BioHebe focuses on funding and shaping therapies that reverse degenerative diseases during the preclinical to company-formation transition, emphasizing exceptional in vivo results from academic and hospital labs.
Focus narrative
BioHebe invests in a range of therapies, including gene and RNA vectors, biologics, small-molecule compounds, and stem cells, alongside diagnostics that support these therapies. The organization is dedicated to commercializing preclinical therapies aimed at conditions such as glaucoma, idiopathic pulmonary fibrosis, end-stage liver disease, and inherited diseases like Usher Syndrome.
Value beyond capital
BioHebe provides strategic support and funding to preclinical assets, helping to translate scientific discoveries into viable business opportunities. The firm emphasizes collaboration with academic and clinical partners to ensure that therapies are developed with a strong foundation of in vivo evidence.
Focus and fit
- Stages
- Pre-seed
- Sectors
- Biotech · Healthcare · Diagnostics
- Regions
- United StatesEurope
Availability
- Currently deploying
- Not published
Common questions
What to know about BioHebe LLC
Upseed classifies BioHebe LLC under the Venture Studio organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 3, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.